[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.168.21. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
July 12, 2006

Treatment-Refractory Depression—Reply

Author Affiliations
 

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2006;296(2):167-168. doi:10.1001/jama.296.2.167-c

In Reply: Dr Rovin asks about the current status of VNS and deep brain stimulation for treatment-refractory depression and their possible use for Ms A. Vagus nerve stimulation requires surgical implantation of a small stimulator that can be turned on by the patient as needed. Modest antidepressant efficacy was seen over a 1-year period in 2 recent cohort studies1,2 but not in a 10-week randomized controlled trial.3 Common adverse events were voice alteration (68%), cough (29%), and dyspnea (23%), along with dysphasia and neck pain (21%). Infection was observed in 8% of the patients.3 The mechanism of VNS antidepressant affect is unknown, but preliminary results suggest that this treatment normalizes the hypothalamic-pituitary-adrenal stress axis.4 Deep brain stimulation is an experimental procedure that is reported to have an antidepressant effect.5 It is not approved for clinical use.

First Page Preview View Large
First page PDF preview
First page PDF preview
×